1-4 of 4
Michael Burke, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Epigenetic Modulation Leads to Re-Expression of Relapse Specific Silenced Genes and Induces Chemosensitivity in Childhood Acute Lymphoblastic Leukemia (ALL),

Teena Bhatla, MD, Debra J. Morrison, PhD, Jinhua Wang, PhD, Elizabeth A. Raetz, MD, Michael Burke, MD, Patrick Brown, MD, William L. Carroll, MD
Journal: Blood
Blood (2011) 118 (21): 3455.
https://doi.org/10.1182/blood.V118.21.3455.3455
Published: 2011
Journal Articles

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) for Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (ALL).

Michael Burke, MD, Barb Trotz, BA, BSN, MSN, Qing Cao, MS, Brenda Weigel, MSc, MD, Ashish Kumar, MBBS, PhD, Angela Smith, MD, MS, Michael Verneris, MD
Journal: Blood
Blood (2009) 114 (22): 3377.
https://doi.org/10.1182/blood.V114.22.3377.3377
Published: 2009
Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD
Journal: Blood
Blood (2008) 112 (11): 4393.
https://doi.org/10.1182/blood.V112.11.4393.4393
Published: 2008
Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD
Journal: Blood
Blood (2008) 112 (11): 4399.
https://doi.org/10.1182/blood.V112.11.4399.4399
Published: 2008